Weyerhaeuser market cap WY
Share price times shares outstanding: what the whole company sells for, since 2009.
- Today, Nov 2, 2026
- $15.3B
- Highest close in our data
- $31.1B
- Feb 2022
Weyerhaeuser is worth $15.3B at the close on Nov 2, 2026, at $21.29 a share.
That is down 8% over the last year and down 47% over five years.
Its highest close in our data was $31.1B in Feb 2022.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $15.3B | $13.3B | $19.5B | −10% |
| 2025 | $17.1B | $15.6B | $22.2B | −16% |
| 2024 | $20.3B | $20B | $26.2B | −20% |
| 2023 | $25.4B | $20.7B | $26B | +11% |
| 2022 | $22.8B | $21.1B | $31.1B | −26% |
| 2021 | $30.8B | $23.3B | $30.8B | +23% |
| 2020 | $25B | $11B | $25.3B | +12% |
| 2019 | $22.3B | $17B | $22.5B | +37% |
| 2018 | $16.4B | $15.9B | $28.8B | −39% |
| 2017 | $26.6B | $22.6B | $27.4B | +18% |
| 2016 | $22.5B | $11.5B | $24.6B | +47% |
| 2015 | $15.3B | $14B | $19.2B | −20% |
| 2014 | $19.2B | $16.2B | $19.4B | +5% |
| 2013 | $18.2B | $15B | $18.3B | +22% |
| 2012 | $14.9B | $10.1B | $15.2B | +49% |
| 2011 | $10B | $8.3B | $13.5B | −1% |
| 2010 | $10.1B | $3.3B | $22.5B | −44% |
| 2009 | $18.2B | $14.8B | $18.7B | n/a |
Against its peers
Companies in REIT - Specialty nearest Weyerhaeuser's size, closest first, today.
| Company | Market cap |
|---|---|
| WYWeyerhaeuser | $15.3B |
| WPCW. P. Carey | $14.8B |
| LAMRLamar Advertising | $16B |
| OHIOmega Healthcare Investors | $14.2B |
| KIMKimco Realty | $16.8B |
| NLYAnnaly Capital Management | $13.9B |
| REGRegency Centers | $13.8B |
| MAAMID America Apartment Communities | $13.7B |
| HSTHost Hotels & Resorts | $17.5B |
| DOCHealthpeak Properties | $13.4B |
| SBACSBA Communications | $19.6B |
| Peer median | $14.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Weyerhaeuser
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.